Literature DB >> 21119623

Elimination pathways of systemically delivered siRNA.

Yuanyu Huang1, Junmei Hong, Shuquan Zheng, Yi Ding, Shutao Guo, Hongyan Zhang, Xiuqin Zhang, Quan Du, Zicai Liang.   

Abstract

The elimination process of systemically administered small interfering RNA (siRNA) was investigated by using siRNA labeled with an infrared fluorescent dye. A novel siRNA elimination pathway was identified. In this pathway, liver-enriched siRNA is secreted into the gallbladder and then emptied into the intestine. Blocking this pathway resulted in the absence of siRNA fluorescence within the intestine, with greatly enhanced siRNA accumulation in liver and gallbladder at the same time. Furthermore, we demonstrated that delivery carriers play an essential role in siRNA distribution and elimination, highlighting their importance in siRNA therapeutics.

Mesh:

Substances:

Year:  2010        PMID: 21119623      PMCID: PMC3034859          DOI: 10.1038/mt.2010.266

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  11 in total

1.  Comprehensive analysis of sequence-specific stability of siRNA.

Authors:  Junmei Hong; Yuanyu Huang; Jun Li; Fan Yi; Jie Zheng; Huang Huang; Na Wei; Yongqiang Shan; Mingrui An; Hongyan Zhang; Jianguo Ji; Peizhuo Zhang; Zhen Xi; Quan Du; Zicai Liang
Journal:  FASEB J       Date:  2010-08-23       Impact factor: 5.191

2.  Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells.

Authors:  Andrzej Ptasznik; Yuji Nakata; Anna Kalota; Stephen G Emerson; Alan M Gewirtz
Journal:  Nat Med       Date:  2004-10-24       Impact factor: 53.440

3.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs.

Authors:  David V Morrissey; Jennifer A Lockridge; Lucinda Shaw; Karin Blanchard; Kristi Jensen; Wendy Breen; Kimberly Hartsough; Lynn Machemer; Susan Radka; Vasant Jadhav; Narendra Vaish; Shawn Zinnen; Chandra Vargeese; Keith Bowman; Chris S Shaffer; Lloyd B Jeffs; Adam Judge; Ian MacLachlan; Barry Polisky
Journal:  Nat Biotechnol       Date:  2005-07-24       Impact factor: 54.908

4.  PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.

Authors:  Sun Hwa Kim; Ji Hoon Jeong; Soo Hyun Lee; Sung Wan Kim; Tae Gwan Park
Journal:  J Control Release       Date:  2006-06-03       Impact factor: 9.776

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

7.  Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging.

Authors:  Derek W Bartlett; Helen Su; Isabel J Hildebrandt; Wolfgang A Weber; Mark E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

8.  Mechanisms and optimization of in vivo delivery of lipophilic siRNAs.

Authors:  Christian Wolfrum; Shuanping Shi; K Narayanannair Jayaprakash; Muthusamy Jayaraman; Gang Wang; Rajendra K Pandey; Kallanthottathil G Rajeev; Tomoko Nakayama; Klaus Charrise; Esther M Ndungo; Tracy Zimmermann; Victor Koteliansky; Muthiah Manoharan; Markus Stoffel
Journal:  Nat Biotechnol       Date:  2007-09-16       Impact factor: 54.908

9.  Radiolabeling small RNA with technetium-99m for visualizing cellular delivery and mouse biodistribution.

Authors:  Ning Liu; Hongliu Ding; Jean-Luc Vanderheyden; Zhihong Zhu; Yumin Zhang
Journal:  Nucl Med Biol       Date:  2007-05       Impact factor: 2.408

10.  Modulation of HIV-1 replication by RNA interference.

Authors:  Jean-Marc Jacque; Karine Triques; Mario Stevenson
Journal:  Nature       Date:  2002-06-26       Impact factor: 69.504

View more
  36 in total

Review 1.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

2.  Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice.

Authors:  Amy Brock; Silva Krause; Hu Li; Marek Kowalski; Michael S Goldberg; James J Collins; Donald E Ingber
Journal:  Sci Transl Med       Date:  2014-01-01       Impact factor: 17.956

Review 3.  Delivery materials for siRNA therapeutics.

Authors:  Rosemary Kanasty; Joseph Robert Dorkin; Arturo Vegas; Daniel Anderson
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

4.  Dextran functionalization enhances nanoparticle-mediated siRNA delivery and silencing.

Authors:  Daniel Vocelle; Olivia M Chesniak; Amanda P Malefyt; Georgina Comiskey; Kwasi Adu-Berchie; Milton R Smith; Christina Chan; S Patrick Walton
Journal:  Technology (Singap World Sci)       Date:  2016-03-31

Review 5.  Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma.

Authors:  Rossella Farra; Mario Grassi; Gabriele Grassi; Barbara Dapas
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

Review 6.  Non-viral vectors for gene-based therapy.

Authors:  Hao Yin; Rosemary L Kanasty; Ahmed A Eltoukhy; Arturo J Vegas; J Robert Dorkin; Daniel G Anderson
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

Review 7.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

Review 8.  Recent advances in hepatocellular carcinoma therapy.

Authors:  Rinku Dutta; Ram I Mahato
Journal:  Pharmacol Ther       Date:  2017-02-05       Impact factor: 12.310

9.  Self-assembled Micelle Interfering RNA for Effective and Safe Targeting of Dysregulated Genes in Pulmonary Fibrosis.

Authors:  Pyoung Oh Yoon; Jin Wook Park; Chang-Min Lee; Sung Hwan Kim; Han-Na Kim; Youngho Ko; Seon Joo Bae; Sungil Yun; Jun Hong Park; Taewoo Kwon; Woo Seok Kim; Jiyoung Lee; Qing Lu; Hye-Ryun Kang; Won-Kyung Cho; Jack A Elias; Joo-Sung Yang; Han-Oh Park; Kyuhong Lee; Chun Geun Lee
Journal:  J Biol Chem       Date:  2016-01-27       Impact factor: 5.157

10.  Inorganic Nanomaterial-Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities.

Authors:  Guanyou Lin; Richard A Revia; Miqin Zhang
Journal:  Adv Funct Mater       Date:  2020-10-13       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.